Longer Transfer Gap to Adult Care Increases Inpatient Encounters in Sickle Cell Disease
By Elana Gotkine HealthDay Reporter
FRIDAY, May 31, 2024 -- For young adults (YAs) with sickle cell disease (SCD), a longer transfer gap is associated with increased inpatient encounters and decreased outpatient encounters in adult health care, according to a study published online May 29 in Blood Advances.
Kristen E. Howell, Ph.D., M.P.H., from Texas A&M University in College Station, and colleagues estimated the association between transfer gaps after completion of pediatric care and the rate of inpatient, emergency department, and outpatient visits among patients with SCD. Health care utilization was assessed in a mid-South comprehensive program for up to eight years from 2012 to 2020. Overall, 183 YAs with SCD transferred to adult health care between 2012 and 2018.
The researchers found that YAs with transfer gaps of six or more versus less than two months had 2.01 and 1.89 times greater rates of hospitalizations in the eight-year follow-up and when restricted to the first two years of adult health care, respectively. Those with transfer gaps of six or more versus less than two months had a 1.75 times higher rate of emergency department encounters in the first two years of adult care. The rate of outpatient visits was 0.71 times greater for those with gaps at two or more to less than six months versus less than two months.
"SCD transition programs should incorporate these findings into their curriculum and strive for transfer gaps as short as possible (ideally shorter than two months) and no longer than six months," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted May 2024
Read this next
Hydroxyurea Has Sustained Clinical Benefits in Children With Sickle Cell Anemia
TUESDAY, April 29, 2025 -- For children with sickle cell anemia (SCA), hydroxyurea has sustained clinical benefits in terms of reducing emergency department visits and hospital...
C-Reactive Protein Increases During Menstrual Cycle in Females With Sickle Cell Disease
TUESDAY, April 15, 2025 -- For adults with sickle cell disease (SCD), C-reactive protein (CRP) levels increase significantly during the follicular phase of the menstrual cycle...
No Evidence Found Linking Sickle Cell Trait With Unexplained Sudden Death
MONDAY, Feb. 3, 2025 -- There is no evidence to support physical exertion without rhabdomyolysis or heat injury causing sudden death in individuals with sickle cell trait (SCT)...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.